|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.00(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
32,136 |
392,652 |
607,225 |
795,101 |
Total Sell Value |
$1,498,005 |
$22,016,859 |
$33,327,809 |
$40,665,283 |
Total People Sold |
3 |
5 |
9 |
10 |
Total Sell Transactions |
5 |
13 |
27 |
63 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-23 |
4 |
AS |
$22.65 |
$90,600 |
D/D |
(4,000) |
37,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-23 |
4 |
OE |
$10.48 |
$41,920 |
D/D |
4,000 |
41,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-22 |
4 |
AS |
$22.35 |
$67,050 |
D/D |
(3,000) |
37,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-22 |
4 |
OE |
$10.48 |
$31,440 |
D/D |
3,000 |
40,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-16 |
4 |
AS |
$22.15 |
$70,326 |
D/D |
(3,175) |
37,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-16 |
4 |
OE |
$10.48 |
$33,274 |
D/D |
3,175 |
40,638 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-14 |
4 |
AS |
$22.15 |
$177 |
D/D |
(8) |
37,463 |
|
- |
|
Liawatidewi Yakob |
SVP Corp Admin Center |
|
2019-01-14 |
4 |
OE |
$10.48 |
$84 |
D/D |
8 |
37,471 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2019-01-02 |
4 |
AS |
$19.52 |
$63,354 |
D/D |
(3,245) |
75,550 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-12-14 |
4 |
S |
$20.48 |
$892,309 |
D/D |
(43,577) |
2,072,317 |
|
- |
|
Prins Richard K |
Director |
|
2018-12-14 |
4 |
S |
$20.65 |
$33,370 |
D/D |
(1,616) |
33,818 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-12-13 |
4 |
S |
$20.99 |
$623,166 |
I/I |
(29,689) |
7,327,679 |
|
- |
|
Applied Physics & Chemistry Laboratories, Inc. |
10% Owner |
|
2018-12-13 |
4 |
S |
$20.99 |
$623,166 |
D/D |
(29,689) |
7,327,679 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-12-12 |
4 |
S |
$21.21 |
$794,736 |
I/I |
(37,469) |
7,357,368 |
|
- |
|
Applied Physics & Chemistry Laboratories, Inc. |
10% Owner |
|
2018-12-12 |
4 |
S |
$21.21 |
$794,736 |
D/D |
(37,469) |
7,357,368 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2018-12-11 |
4 |
S |
$21.43 |
$1,433,150 |
I/I |
(66,757) |
7,394,837 |
|
- |
|
Applied Physics & Chemistry Laboratories, Inc. |
10% Owner |
|
2018-12-11 |
4 |
S |
$21.43 |
$1,433,150 |
D/D |
(66,757) |
7,394,837 |
|
- |
|
Koo Richard |
Director |
|
2018-12-11 |
4 |
S |
$21.32 |
$624,075 |
D/D |
(29,278) |
241,928 |
|
- |
|
Koo Richard |
Director |
|
2018-12-11 |
4 |
OE |
$14.66 |
$429,215 |
D/D |
29,278 |
271,206 |
|
- |
|
Shohet Stephen B. |
Director |
|
2018-12-10 |
4 |
S |
$21.72 |
$1,271,782 |
D/D |
(58,557) |
30,706 |
|
- |
|
Shohet Stephen B. |
Director |
|
2018-12-10 |
4 |
OE |
$14.66 |
$858,446 |
D/D |
58,557 |
89,263 |
|
- |
|
Lee Howard |
Director |
|
2018-12-07 |
4 |
S |
$21.89 |
$203,064 |
D/D |
(9,278) |
123,381 |
|
- |
|
Lee Howard |
Director |
|
2018-12-07 |
4 |
OE |
$14.66 |
$136,015 |
D/D |
9,278 |
132,659 |
|
- |
|
Lee Howard |
Director |
|
2018-12-06 |
4 |
S |
$20.91 |
$212,242 |
D/D |
(10,000) |
123,381 |
|
- |
|
Lee Howard |
Director |
|
2018-12-06 |
4 |
OE |
$14.66 |
$146,600 |
D/D |
10,000 |
133,381 |
|
- |
|
956 Records found
|
|
Page 21 of 39 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|